In vivo tumor detection using polarization and wavelength reflection characteristics of gold nanorods.

This paper presents a novel concept involving sensing the back-reflected and absorbed light at two polarization states and at several wavelengths from gold nanorods (GNRs). While the GNRs are flowing in the bloodstream the reflected light has a high degree of polarization and only one resonance wavelength. When the GNRs are located in a tumor the reflected light has a low degree of polarization and two resonance wavelengths are detected. Such characteristics can assist in detecting a tumor in passive targeting and without labeling it.

[1]  Hao Hong,et al.  In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles. , 2013, ACS nano.

[2]  Jimin Liang,et al.  In vivo gastric cancer targeting and imaging using novel symmetric cyanine dye-conjugated GX1 peptide probes. , 2013, Bioconjugate chemistry.

[3]  Huanjun Chen,et al.  Gold Nanorods and Their Plasmonic Properties , 2013 .

[4]  Menachem Motiei,et al.  Intercoupling surface plasmon resonance and diffusion reflection measurements for real‐time cancer detection , 2013, Journal of biophotonics.

[5]  Dror Fixler,et al.  Errata: Subcutaneous gold nanorods detection with diffusion reflection measurement , 2013 .

[6]  Hamootal Duadi,et al.  In‐vivo Tumor detection using diffusion reflection measurements of targeted gold nanorods – a quantitative study , 2012, Journal of biophotonics.

[7]  Menachem Motiei,et al.  A new method for cancer detection based on diffusion reflection measurements of targeted gold nanorods , 2012, International journal of nanomedicine.

[8]  A. Popovtzer,et al.  Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study , 2011, International journal of nanomedicine.

[9]  Dror Fixler,et al.  Reflected light intensity profile of two-layer tissues: phantom experiments. , 2011, Journal of biomedical optics.

[10]  D. Siemann,et al.  The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents. , 2011, Cancer treatment reviews.

[11]  Kristina M. Cook,et al.  Angiogenesis Inhibitors: Current Strategies and Future Prospects , 2010, CA: a cancer journal for clinicians.

[12]  Ekaterina I. Galanzha,et al.  Nanotechnology‐based molecular photoacoustic and photothermal flow cytometry platform for in‐vivo detection and killing of circulating cancer stem cells , 2009, Journal of biophotonics.

[13]  Helen X. Chen,et al.  Adverse effects of anticancer agents that target the VEGF pathway , 2009, Nature Reviews Clinical Oncology.

[14]  B. Pogue,et al.  Tutorial on diffuse light transport. , 2008, Journal of biomedical optics.

[15]  A. D. Van den Abbeele,et al.  Major response to imatinib mesylate in KIT-mutated melanoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  H. Verheul,et al.  Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition , 2007, Nature Reviews Cancer.

[17]  C. Lindley,et al.  Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. , 2006, Clinical therapeutics.

[18]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[19]  Carsten Sönnichsen,et al.  Plasmons in metal nanostructures , 2001 .

[20]  R. Weissleder.  A clearer vision for in vivo imaging , 2001, Nature Biotechnology.

[21]  P. Harari,et al.  Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. , 1999, Cancer research.

[22]  P. Harari,et al.  Epidermal Growth Factor Receptor Blockade with C 225 Modulates Proliferation , Apoptosis , and Radiosensitivity in Squamous Cell Carcinomas of the Head and Neck 1 , 1999 .

[23]  C. R. Chris Wang,et al.  Gold Nanorods: Electrochemical Synthesis and Optical Properties. , 1997 .